• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Primary Prevention for Intermediate Risk: The More Things Change, the More They Stay the Same.

作者信息

Greenland Philip, Glynn Peter A

机构信息

Department of Preventive Medicine, Northwestern University Feinberg School of Medicine, Chicago, Illinois, USA.

Department of Medicine (Cardiology), Northwestern University Feinberg School of Medicine, Chicago, Illinois, USA.

出版信息

JACC Adv. 2024 Mar 5;3(4):100884. doi: 10.1016/j.jacadv.2024.100884. eCollection 2024 Apr.

DOI:10.1016/j.jacadv.2024.100884
PMID:38939677
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11198644/
Abstract
摘要
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/78fd/11198644/e5a3450c9972/ga1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/78fd/11198644/e5a3450c9972/ga1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/78fd/11198644/e5a3450c9972/ga1.jpg

相似文献

1
Primary Prevention for Intermediate Risk: The More Things Change, the More They Stay the Same.中度风险的一级预防：万变不离其宗。
JACC Adv. 2024 Mar 5;3(4):100884. doi: 10.1016/j.jacadv.2024.100884. eCollection 2024 Apr.
2
Comparative effectiveness and cost-effectiveness of computed tomography screening for coronary artery calcium in asymptomatic individuals.计算机断层扫描筛查无症状个体冠状动脉钙的比较效果和成本效益。
J Am Coll Cardiol. 2011 Oct 11;58(16):1690-701. doi: 10.1016/j.jacc.2011.05.056.
3
Cost-Effectiveness of Using the Coronary Artery Calcium Score in Guiding Therapeutic Decisions in Primary Prevention in the Brazilian Population.在巴西人群的一级预防中使用冠状动脉钙评分指导治疗决策的成本效益。
Arq Bras Cardiol. 2022 Jun 10;118(6):1126-1131. doi: 10.36660/abc.20210347. eCollection 2022.
4
Using the coronary artery calcium score to guide statin therapy: a cost-effectiveness analysis.使用冠状动脉钙化评分指导他汀类药物治疗：一项成本效益分析。
Circ Cardiovasc Qual Outcomes. 2014 Mar;7(2):276-84. doi: 10.1161/CIRCOUTCOMES.113.000799. Epub 2014 Mar 11.
5
Strategies for Primary Prevention of Coronary Heart Disease Based on Risk Stratification by the ACC/AHA Lipid Guidelines, ATP III Guidelines, Coronary Calcium Scoring, and C-Reactive Protein, and a Global Treat-All Strategy: A Comparative--Effectiveness Modeling Study.基于美国心脏病学会/美国心脏协会血脂指南、ATP III指南、冠状动脉钙化评分和C反应蛋白进行风险分层的冠心病一级预防策略，以及全球全治疗策略：一项比较有效性建模研究
PLoS One. 2015 Sep 30;10(9):e0138092. doi: 10.1371/journal.pone.0138092. eCollection 2015.
6
Coronary Artery Calcium Versus Pooled Cohort Equations Score for Primary Prevention Guidance: Randomized Feasibility Trial.冠状动脉钙化与用于一级预防指导的合并队列方程评分：随机可行性试验。
JACC Cardiovasc Imaging. 2022 May;15(5):843-855. doi: 10.1016/j.jcmg.2021.11.006. Epub 2021 Dec 15.
7
Cost-Effectiveness of Coronary Artery Calcium Scoring in People With a Family History of Coronary Disease.有冠心病家族史人群中冠状动脉钙评分的成本效益。
JACC Cardiovasc Imaging. 2021 Jun;14(6):1206-1217. doi: 10.1016/j.jcmg.2020.11.008. Epub 2021 Jan 13.
8
Cardiac Society of Australia and New Zealand Position Statement: Coronary Artery Calcium Scoring.澳大利亚和新西兰心脏学会立场声明：冠状动脉钙化评分
Heart Lung Circ. 2017 Dec;26(12):1239-1251. doi: 10.1016/j.hlc.2017.05.130. Epub 2017 Jun 16.
9
A systematic review and economic evaluation of statins for the prevention of coronary events.他汀类药物预防冠状动脉事件的系统评价与经济学评估
Health Technol Assess. 2007 Apr;11(14):1-160, iii-iv. doi: 10.3310/hta11140.
10
Intravenous magnesium sulphate and sotalol for prevention of atrial fibrillation after coronary artery bypass surgery: a systematic review and economic evaluation.静脉注射硫酸镁和索他洛尔预防冠状动脉搭桥术后房颤：系统评价与经济学评估
Health Technol Assess. 2008 Jun;12(28):iii-iv, ix-95. doi: 10.3310/hta12280.

本文引用的文献

1
Statin Use and Eligibility for Primary Prevention of Atherosclerotic Cardiovascular Disease Among Adults at Borderline or Intermediate Risk in the United States.美国边缘或中度风险成年人中他汀类药物的使用与动脉粥样硬化性心血管疾病一级预防的适用性
J Am Heart Assoc. 2023 Apr 18;12(8):e029263. doi: 10.1161/JAHA.122.029263. Epub 2023 Apr 7.
2
Statin Use for the Primary Prevention of Cardiovascular Disease in Adults: US Preventive Services Task Force Recommendation Statement.他汀类药物用于成年人的心血管疾病一级预防：美国预防服务工作组推荐声明。
JAMA. 2022 Aug 23;328(8):746-753. doi: 10.1001/jama.2022.13044.
3
Prevalence and significance of risk enhancing biomarkers in the United States population at intermediate risk for atherosclerotic disease.
美国动脉粥样硬化疾病中度风险人群中风险增强生物标志物的患病率及意义。
J Clin Lipidol. 2022 Jan-Feb;16(1):66-74. doi: 10.1016/j.jacl.2021.11.009. Epub 2021 Dec 1.
4
Cardiovascular Disease Risk-Based Statin Utilization and Associated Outcomes in a Primary Prevention Cohort: Insights From a Large Health Care Network.基于心血管疾病风险的他汀类药物利用与主要预防队列中的相关结局：来自大型医疗保健网络的见解。
Circ Cardiovasc Qual Outcomes. 2021 Sep;14(9):e007485. doi: 10.1161/CIRCOUTCOMES.120.007485. Epub 2021 Aug 30.
5
2021 Canadian Cardiovascular Society Guidelines for the Management of Dyslipidemia for the Prevention of Cardiovascular Disease in Adults.2021 加拿大心血管学会成人血脂异常管理指南：预防心血管疾病
Can J Cardiol. 2021 Aug;37(8):1129-1150. doi: 10.1016/j.cjca.2021.03.016. Epub 2021 Mar 26.
6
2019 ACC/AHA Guideline on the Primary Prevention of Cardiovascular Disease: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines.2019美国心脏病学会/美国心脏协会心血管疾病一级预防指南：美国心脏病学会/美国心脏协会临床实践指南工作组报告
J Am Coll Cardiol. 2019 Sep 10;74(10):e177-e232. doi: 10.1016/j.jacc.2019.03.010. Epub 2019 Mar 17.
7
Vulnerabilities to Health Disparities and Statin Use in the REGARDS (Reasons for Geographic and Racial Differences in Stroke) Study.REGARDS 研究（地理和种族差异导致中风的原因）中存在的健康差异和他汀类药物使用的脆弱性。
J Am Heart Assoc. 2017 Aug 28;6(9):e005449. doi: 10.1161/JAHA.116.005449.
8
Implications of Coronary Artery Calcium Testing for Treatment Decisions Among Statin Candidates According to the ACC/AHA Cholesterol Management Guidelines: A Cost-Effectiveness Analysis.根据美国心脏病学会/美国心脏协会胆固醇管理指南，冠状动脉钙测试对他汀类药物候选者治疗决策的影响：成本效益分析。
JACC Cardiovasc Imaging. 2017 Aug;10(8):938-952. doi: 10.1016/j.jcmg.2017.04.014.
9
Role of Coronary Artery Calcium Score of Zero and Other Negative Risk Markers for Cardiovascular Disease: The Multi-Ethnic Study of Atherosclerosis (MESA).冠状动脉钙化评分为零及其他心血管疾病阴性风险标志物的作用：动脉粥样硬化多民族研究（MESA）
Circulation. 2016 Mar 1;133(9):849-58. doi: 10.1161/CIRCULATIONAHA.115.018524. Epub 2016 Jan 22.
10
Coronary artery calcium score and risk classification for coronary heart disease prediction.冠状动脉钙评分与冠心病风险分类预测。
JAMA. 2010 Apr 28;303(16):1610-6. doi: 10.1001/jama.2010.461.